OM:SOBIBiotechs
Swedish Orphan Biovitrum Q4 Margin Rebound Challenges Bearish Earnings Volatility Narrative
Swedish Orphan Biovitrum (OM:SOBI) has closed out FY 2025 with Q4 revenue of SEK 7.8b and basic EPS of SEK 5.39, alongside net income of SEK 1,861m, giving investors a clear snapshot of how the year finished after a volatile run of quarterly results. Over recent periods, the company has seen revenue move from SEK 7.4b and EPS of SEK 4.07 in Q4 2024 to SEK 7.8b and EPS of SEK 5.39 in Q4 2025. The interim quarters ranged from SEK 6.2b to SEK 7.8b in revenue, with EPS swinging between a loss of...